ML18206A774
| ML18206A774 | |
| Person / Time | |
|---|---|
| Site: | 03001249 |
| Issue date: | 07/03/2018 |
| From: | Lanzisera P A NRC Region 1 |
| To: | Bristol Hosp |
| References | |
| 608739 | |
| Download: ML18206A774 (4) | |
Text
NRC FORM 374 U.S. NUCLEAR REGULATORY COMMISSION MATERIALS LICENSE PAGE 1 OF 4 PAGES Amendment No. 44 Pursuant to the Atomic Energy Act of 1954 , as amended , the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10 , Code of Federal Regulations , Chapter I , Parts 30, 31 , 32 , 33, 34 , 35 , 36 , 37 , 39, 40 , 70 and 71', and in reliance on statements and representations heretofore made by the licensee , a license is hereby issued authorizing the licensee to receive, acquire , possess , and transfer byproduct , source, and special nuclear material designated below; to use such material for the purpose(s) and at the place(s) designated below; to deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended , and is subject to all applicable rules , regulations , and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any conditions specified below. 1. Bristol Hospital, Inc. 2. P.O. Box 977 41 Brewster Road Bristol, CT 06011 Licensee .~* In accordance with letter dated January_ 02,_20.:18. 3. License number: 06-02057-0ns amended in its entirety to read as follows: 4. Expiration Date: February 28, 2025 5. Docket No.: 030-01249 Reference No.: 6. Byproduct , source , and/or special nuclear material 7. Chemical and/or physical form 8. Maximum amount that licensee 9. Author i zed use may possess at any one time A. Any byproduct material A. permitted by 10 CFR 35.100 B. Any byproduct material B. permitted by 1 O CFR 35.200 C. Any byproduct material C. permitted by 10 CFR 35.300 Any Any Any ,> under this license A. As Needed ' B. As Needed ~* C. 500 millicuries total *~ A. For use in uptake , dilution and excretion studies permitted by 10 CFR 35.100. B. For use in imaging and localization studies permitted by 10 CFR 35.200. C. Any sodium iodide iodine-131 diagnostic study or therapy procedure permitted by 10 CFR 35.300 in quantities less than or equal to 33 millicuries. Parenteral administration of any beta emitter or a photon-emitting radionuclide with a photon energy less than 150 keV permitted by 10 CFR 35.300 NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 2 OF 4 PAGES License Number MATERIALS LICENSE SUPPLEMENTARY SHEET 06-02057-01 Amendment No. 44 6. Byproduct , source , and/or special nuclear material D. lodine-125 permitted by 10 CFR 35.400 E. Cesium-131 perm i tted by 10 CFR 35.400 7. Chemical and/or physical form D. Sealed Sources (Isa-Aid L.t: C., Model IAl-125A; The~genics Corporation , Model AgX100) E. Sealed Sources)soRay, Model CS-1) ..... Docket o r Reference Number 030-01249
- 8. Maximum amount that licensee 9. Authorized use may possess at any one time under this license D. 1 curie total E. 500 millicuries total CONDITIONS
\. ' D. For any manual brachytherapy procedure permitted by 10 CFR 35.400. E. For any manual brachytherapy procedure permitted by 10 CFR 35.400. 10. Licensed material may be used or ston~d only at the licensee's facilities located at 41 Brewster Road , Bristol , Connecticut.
- 11. The Radiation Safety Officer for this license is Stewart E. Bober, M.D. 12. Licensed material shall only be used by , or-u o der the supervision of: ' A. Individuals permitted to work as authorized users in accordance with 1 O CFR 35.13 and 10 CFR 35.14.
NRC FORM 374A MATERIALS LICENSE SUPPLEMENTARY SHEET U.S. NUCLEAR REGULATORY COMMISSION License Number 06-02057-01 Amendment No. 44 Docket or Reference Number 030-01249 P AGE 3 OF 4 PAG E S B. The following individuals are authorized users for the materiaLand medical uses as indicated:
Authorized Users Material and'Use Carlos M. Badiola, M.D. 10 CFR 35~100 , 10 CFR 35.200 Jeffrey A. Bitterman , M.D. 10 J SFR 35.400 ... Stewart E. Bober , M.D. *10 CFR 35.100, 10 CFR 35.200 Douglas Houseman , M.D. Jeffrey Kaye, M.D. Christopher J. Leary, M.D. Joseph Revalese , 111 , M.D. Folco Scappaticci , M.D. 10 CFR 35.400 1 O CFR 35.100, 1 O CFR 35.200; Oral administration of sodium iodide 1-131 i n quantities less than or equal to 33 millicuries 10 CFR 35.100, 10 CFR 35.200; Oral administration of sodium iodide 1-131 in quantities less than or equal to 33 millicuries; Parenteral admi nis tration of any beta emitter , or photon-emitting radionuclide with a photon energy less than 150 keV, for which a written directive is required 10 CF;,R 35.400 .,a_ 10 CFR 35.100,10 CFR 35.200 -' 13. In addition to the possession limits in Item 8, the~licensee shalkfurth~r restrict the possession of licensed material to quantities below the minimum limit specified in 10 CFR 30.35(d) for 1 stablishing decomm i ssioning financial-assurance.
NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PA G E 4 O F 4 PAGES MATERIALS LICENSE SUPPLEMENTARY SHEET L i cense Number 06-02057-01 Amendment No. 44 Doc k et o r Reference Number 030-01249
- 14. Except as specifically provided otherw i se in this license , the licensee-s_hall conduct its program in accordance with the statements , representations , and procedures contained in the document s , including a n y enclosures, listed below. This license condition applies only to those procedures that are required to be submitted'in ~c;rdance with the regulations. Additionally , this license condition does not limit the licensee's ability to make changes to the radiatio h.pr~ection program as provided for in 10 CFR 35.26. The U.S. Nuclear Regulatory Commission's regulations shall govern unless the statements , representations, and pr o cedures in the licensee's application and -... correspondence are more restrictive than the regulations. A. Application dated September 24 , 2014 [ML 14272A365]
B. Letter dated January 20 , 2015 [ML 15048A020]
'~ Date: July 3 , 2018 FOR THE U,,,B. NUCLEAR REGULATORY COMMISSION
/~ -By: T c..--~ .. 7// '--z_, ; zj Penny Lanzisera Region 1